The 3-(3,4-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay measured cell viability by assessing the ability of mitochondria to metabolize the yellow tetrazolium salt MTT to purple insoluble crystals of formazan [38,39]. Both SH-SY5Y and rat primary cortical neurons were plated on 12-well plates, and at the end of the experimental procedure, the cells were incubated with 0.5 mL of MTT solution (0.5 mg/mL in PBS) in the dark at 37 °C and a 5% CO2 atmosphere in a humidified incubator. After 1 h, the cells were washed with PBS, and the produced formazan crystals were dissolved in 0.5 mL of DMSO [15,40]. A decrease in mitochondrial activity resulted in a reduction in the amount of formazan produced and therefore in the absorbance value. Absorbance was read at a wavelength of 540 nm using a Victor Multilabel Counter plate reader (Perkin Elmer, Waltham, MA, USA). The results were expressed as percentages of the control value.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.